727 related articles for article (PubMed ID: 21929662)
1. Validating Migraine-Specific Quality of Life Questionnaire v2.1 in episodic and chronic migraine.
Bagley CL; Rendas-Baum R; Maglinte GA; Yang M; Varon SF; Lee J; Kosinski M
Headache; 2012 Mar; 52(3):409-21. PubMed ID: 21929662
[TBL] [Abstract][Full Text] [Related]
2. Validation of the Korean Migraine-Specific Quality of Life Questionnaire Version 2.1 in Episodic and Chronic Migraine.
Seo JG; Park SP
J Oral Facial Pain Headache; 2017 Summer; 31(3):251-256. PubMed ID: 28738110
[TBL] [Abstract][Full Text] [Related]
3. Headache impact of chronic and episodic migraine: results from the American Migraine Prevalence and Prevention study.
Buse D; Manack A; Serrano D; Reed M; Varon S; Turkel C; Lipton R
Headache; 2012 Jan; 52(1):3-17. PubMed ID: 22106869
[TBL] [Abstract][Full Text] [Related]
4. Mapping from disease-specific measures to health-state utility values in individuals with migraine.
Gillard PJ; Devine B; Varon SF; Liu L; Sullivan SD
Value Health; 2012 May; 15(3):485-94. PubMed ID: 22583459
[TBL] [Abstract][Full Text] [Related]
5. Validity and reliability of the Turkish Migraine Disability Assessment (MIDAS) questionnaire.
Ertaş M; Siva A; Dalkara T; Uzuner N; Dora B; Inan L; Idiman F; Sarica Y; Selçuki D; Sirin H; Oğuzhanoğlu A; Irkeç C; Ozmenoğlu M; Ozbenli T; Oztürk M; Saip S; Neyal M; Zarifoğlu M;
Headache; 2004 Sep; 44(8):786-93. PubMed ID: 15330825
[TBL] [Abstract][Full Text] [Related]
6. Psychometric validation and meaningful within-patient change of the Migraine-Specific Quality of Life questionnaire version 2.1 electronic patient-reported outcome in patients with episodic and chronic migraine.
Speck RM; Yu R; Ford JH; Ayer DW; Bhandari R; Wyrwich KW
Headache; 2021 Mar; 61(3):511-526. PubMed ID: 33481276
[TBL] [Abstract][Full Text] [Related]
7. Comparisons of disability, quality of life, and resource use between chronic and episodic migraineurs: a clinic-based study in Taiwan.
Wang SJ; Wang PJ; Fuh JL; Peng KP; Ng K
Cephalalgia; 2013 Feb; 33(3):171-81. PubMed ID: 23203506
[TBL] [Abstract][Full Text] [Related]
8. OnabotulinumtoxinA improves quality of life and reduces impact of chronic migraine.
Lipton RB; Varon SF; Grosberg B; McAllister PJ; Freitag F; Aurora SK; Dodick DW; Silberstein SD; Diener HC; DeGryse RE; Nolan ME; Turkel CC
Neurology; 2011 Oct; 77(15):1465-72. PubMed ID: 21956721
[TBL] [Abstract][Full Text] [Related]
9. The psychometric properties of the Migraine-Specific Quality of Life Questionnaire version 2.1 (MSQ) in chronic migraine patients.
Rendas-Baum R; Bloudek LM; Maglinte GA; Varon SF
Qual Life Res; 2013 Jun; 22(5):1123-33. PubMed ID: 22797868
[TBL] [Abstract][Full Text] [Related]
10. MIDAS and HIT-6 French translation: reliability and correlation between tests.
Magnoux E; Freeman MA; Zlotnik G
Cephalalgia; 2008 Jan; 28(1):26-34. PubMed ID: 17970768
[TBL] [Abstract][Full Text] [Related]
11. The impact of migraine on daily activities: effect of topiramate compared with placebo.
Silberstein SD; Loder E; Forde G; Papadopoulos G; Fairclough D; Greenberg S
Curr Med Res Opin; 2006 Jun; 22(6):1021-9. PubMed ID: 16846536
[TBL] [Abstract][Full Text] [Related]
12. Psychometric Validation of the Role Function Restrictive Domain of the Migraine Specific Quality-of-Life Questionnaire Version 2.1 Electronic Patient-Reported Outcome in Patients With Episodic and Chronic Migraine.
Speck RM; Shalhoub H; Wyrwich KW; Yu R; Ayer DW; Ford J; Bush EN; Lipton RB
Headache; 2019 May; 59(5):756-774. PubMed ID: 30861580
[TBL] [Abstract][Full Text] [Related]
13. Migraine Headache Day Response Rates and the Implications to Patient Functioning: An Evaluation of 3 Randomized Phase 3 Clinical Trials of Galcanezumab in Patients With Migraine.
Ford JH; Kurth T; Starling AJ; Ayer DW; Wietecha LA; Port MD; Rettiganti M; Ruff DD
Headache; 2020 Nov; 60(10):2304-2319. PubMed ID: 33249580
[TBL] [Abstract][Full Text] [Related]
14. Assessing the ability of topiramate to improve the daily activities of patients with migraine.
Brandes JL; Kudrow DB; Rothrock JF; Rupnow MF; Fairclough DL; Greenberg SJ
Mayo Clin Proc; 2006 Oct; 81(10):1311-9. PubMed ID: 17036556
[TBL] [Abstract][Full Text] [Related]
15. Identifying patients who require a change in their current acute migraine treatment: the Migraine Assessment of Current Therapy (Migraine-ACT) questionnaire.
Dowson AJ; Tepper SJ; Baos V; Baudet F; D'Amico D; Kilminster S
Curr Med Res Opin; 2004 Jul; 20(7):1125-35. PubMed ID: 15265257
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
17. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
18. A 3-month analysis of disability, quality of life, and disease course in patients with migraine.
Raggi A; Leonardi M; Bussone G; D'Amico D
Headache; 2013 Feb; 53(2):297-309. PubMed ID: 23094760
[TBL] [Abstract][Full Text] [Related]
19. Cost of health care among patients with chronic and episodic migraine in Canada and the USA: results from the International Burden of Migraine Study (IBMS).
Stokes M; Becker WJ; Lipton RB; Sullivan SD; Wilcox TK; Wells L; Manack A; Proskorovsky I; Gladstone J; Buse DC; Varon SF; Goadsby PJ; Blumenfeld AM
Headache; 2011; 51(7):1058-77. PubMed ID: 21762134
[TBL] [Abstract][Full Text] [Related]
20. Reliability, validity, and clinical utility of the Migraine-ACT questionnaire.
Kilminster SG; Dowson AJ; Tepper SJ; Baos V; Baudet F; D'Amico D
Headache; 2006 Apr; 46(4):553-62. PubMed ID: 16643548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
